NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-04485e-2024-03-14T09:48:01Z",
    "date": "2024-03-14T09:48:01Z",
    "ocid": "ocds-h6vhtk-04485e",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-04485e",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "mainProcurementCategory": "goods",
        "lots": [
            {
                "id": "1",
                "description": "This procurement will be conducted by NHS Arden & Greater East Midlands Commissioning Support Unit on behalf of NHS England Specialised Commissioning.<br/>Contract(s) entered into pursuant to this procurement will be between the successful supplier(s) and NHS England (National Health Service Commissioning Board).<br/>Organisations wishing to participate in the procurement must have at least one Direct Acting Antiviral (DAA) for the treatment of Hepatitis C within their product portfolio. There is no restriction on the number of DAA products that bidders can offer for, or that can be included in the contract(s).<br/>Contract(s) awarded pursuant the procurement exercise are for use by the Department of Health, Public Health England, the NHS in England; and be used by private sector contractors and agents working on behalf of the aforementioned<br/>Appointed suppliers will be responsible for (i) the supply of Hepatitis C DAA treatments and (ii) the provision of Hepatitis C elimination initiatives and/or services to help identify and treat Hepatitis C patients so as to accelerate the elimination of Hepatitis C in England from 1st October 2018. The duration of any Contract(s) awarded will be for an initial period of three (3) years, with an option to extend (at the sole discretion of the contracting authority) for an additional period or periods up to two (2) years.<br/>Further information, including details regarding the Lots, is set out in the procurement documents which are available to download (see below for details)<br/>The contracting authority intends to use the NHS Arden & Greater East Midlands Commissioning Support Unit e-procurement portal in this procurement exercise.<br/>i) To Register - log onto the portal at https://ardengemcsu.bravosolution.co.uk (registration and use of the website is free of charge).<br/>ii) Express interest by:<br/>a) selecting response to advert and PQQ (ref: pqq_483) and ITT (ref: itt_958)<br/>b) select Open Access ITT<br/>c) search for and access listing related to this contract and view details<br/>d) click on Express Interest link<br/>iii) Once you have expressed interest, access the My ITTs page where you can download and complete the ITT.",
                "contractPeriod": {
                    "startDate": "2019-05-01T00:00:00+01:00",
                    "endDate": "2024-03-31T23:59:59+01:00"
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "techniques": {
            "frameworkAgreement": {
                "periodRationale": "The original advertised aim of the contract was to eliminate Hepatitis C in England. This has nearly been achieved but further services and/or supplies are necessary to achieve the elimination targets, as the last groups are harder to reach. It would not be possible to change contractor(s) for technical reasons at this stage of the programme (and no-one else can supply these medicines) and/or to do so would cause substantial inconvenience and duplication of costs.<br/>It was not foreseen that it would take longer than anticipated to get to the hard to reach groups or that the programme would be delayed due to Covid-19. <br/>The modification (i.e. extension) does not alter the overall nature of the contract as (a) the overall aim has not changed; and (b) the Authority are simply requiring more of the same supplies and services for a further two years. <br/>The increase in costs of the modification does not exceed 50% of the original contract value."
            }
        }
    },
    "awards": [
        {
            "id": "008114-2024-01/05/2019-31/03/2024-1",
            "relatedLots": [
                "1"
            ],
            "title": "NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-107729",
                    "name": "Gilead Sciences Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-3022",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House, Quarry Hill",
                "locality": "Leeds",
                "region": "UK",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mark Perkins",
                "email": "mark.perkins@nhs.net"
            },
            "roles": [
                "buyer",
                "mediationBody"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/"
            }
        },
        {
            "id": "GB-FTS-107729",
            "name": "Gilead Sciences Limited",
            "identifier": {
                "legalName": "Gilead Sciences Limited",
                "id": "02543818"
            },
            "address": {
                "streetAddress": "280 High Holborn, London",
                "locality": "London",
                "region": "UK",
                "postalCode": "WC1V 7EE",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "http://www.gilead.com",
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-1661",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3022",
        "name": "NHS England"
    },
    "contracts": [
        {
            "id": "008114-2024-01/05/2019-31/03/2024-1",
            "awardID": "008114-2024-01/05/2019-31/03/2024-1",
            "title": "NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives",
            "status": "active",
            "value": {
                "amount": 1200000000,
                "currency": "GBP"
            },
            "dateSigned": "2019-05-01T00:00:00+01:00",
            "period": {
                "startDate": "2019-05-01T00:00:00+01:00",
                "endDate": "2024-03-31T23:59:59+01:00"
            },
            "periodRationale": "The original advertised aim of the contract was to eliminate Hepatitis C in England. This has nearly been achieved but further services and/or supplies are necessary to achieve the elimination targets, as the last groups are harder to reach. It would not be possible to change contractor(s) for technical reasons at this stage of the programme (and no-one else can supply these medicines) and/or to d",
            "items": [
                {
                    "id": "1",
                    "classification": {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    },
                    "deliveryAddresses": [
                        {
                            "region": "UK"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "amendments": [
                {
                    "id": "1",
                    "description": "Nature and extent of the modifications (with indication of possible earlier changes to the contract):<br/>The contract is to be extended for a further two years. No further modifications are to be made except for the extension in duration [(save that Vosevi shall be added as a Supplier's Treatment but shall not be included when calculating the Supplier's actual market share or Recommended Market Share).]",
                    "rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: The original advertised aim of the contract was to eliminate Hepatitis C in England. This has nearly been achieved but further services and/or supplies are necessary to achieve the elimination targets, as the last groups are harder to reach. It would not be possible to change contractor(s) for technical reasons at this stage of the programme (and no-one else can supply these medicines) and/or to do so would cause substantial inconvenience and duplication of costs.<br/>It was not foreseen that it would take longer than anticipated to get to the hard to reach groups or that the programme would be delayed due to Covid-19. <br/>The modification (i.e. extension) does not alter the overall nature of the contract as (a) the overall aim has not changed; and (b) the Authority are simply requiring more of the same supplies and services for a further two years. <br/>The increase in costs of the modification does not exceed 50% of the original contract value."
                }
            ]
        }
    ],
    "language": "en"
}